Position in ZLAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$453,701
+$4,538 QoQ
Shares Held
23,879
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 92 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. ZLAB ranks #365 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ZLAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $453,701 | 23,879 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $449,163 | 23,879 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $421,225 | 23,879 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,714,020 | 50,576 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,976,574 | 56,522 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,113,900 | 58,492 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,454,068 | 55,520 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,053,131 | 43,626 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $598,214 | 34,519 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $876,470 | 54,711 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,488,145 | 54,451 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,349,496 | 55,512 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,976,122 | 71,263 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,437,063 | 464,133 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,012,677 | 456,439 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,536,102 | 454,272 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,618,417 | 421,523 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,226,113 | 368,943 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $22,404,202 | 356,471 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $34,628,519 | 328,575 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $51,597,363 | 291,527 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $34,623,216 | 259,486 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $31,627,739 | 233,691 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,794,423 | 225,976 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,145,346 | 184,407 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,669,028 | 129,546 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||